Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Operates as a specialty pharmaceutical company.
Year Established: | 2003 |
Funding: | 17.4 |
Address: | Newtown, PA 18940 |
Telephone: | |
Mobile: | |
Fax: | |
Mail: | info@quinnova.com |
Company URL: | http://www.quinnova.com |
Safeguard Scientifics leads $17.4 Million Series B Financing for Quinnova Pharmaceuticals.
Click here to download our October, 2009 press release.
Quinnova Pharmaceuticals, Inc. Announced that it has received FDA clearance on the company's new product NEOSALUS CREAM.
Click here to download our April, 2009 press release.
Quinnova Pharmaceuticals, Inc. Announces Appointment of Senior Vice President Research & Development.
Click here to download our September, 2008 press release.
Quinnova Pharmaceuticals, Inc. announced the commercial launch of Cleanse and Treat, a new acne medication in 2008.
Click here to download our August, 2008 press release.
Quinnova Pharmaceuticals, Inc. announced today the commercial launch of its second, water-lipid based foam prescription drug product utilizing the patented Proderm Technology
H.I.G. Capital LLC,Safeguard Scientifics, Inc.,Thomas, McNerney & Partners LLC ,Undisclosed Firm
Jeffrey S. Day (President; Director; Founding Stockholder)
Mr. Day is a commercial development specialist, whose primary focus and expertise is the dermatology marketplace. He has held strategic sales, marketing, and management positions with major pharmaceutical companies, including Allergan Pharmaceuticals and Ferndale Laboratories. In 2000, Mr. Day founded Rx-Pharma Pharmaceuticals, Inc., a specialty pharmaceutical business with two licensed products ("Pandel" and "Pro-Q") and a delivery platform technology, "Restoraderm." After building a sales force and developing several products utilizing the Restoraderm platform, he successfully negotiated and consummated the sale of Rx-Pharma to CollaGenex Pharmaceuticals, Inc., assuming the position of Vice President, Dermatology at CollaGenex. A key to Mr. Day's success in the pharmaceutical industry is his strong ongoing relationships with the members of the dermatology community and capitalizing on their experience and expertise during the development, launch, and sales of new products. These ongoing working relationships are the basis for building invaluable Advisory Boards, and Steering Committees and aid tremendously in the successful launch of unique prescription drug products.
Duane J. Napolitana (Vice President, Finance)
Prior to joining Quinnova Pharmaceuticals, Inc. Mr. Napolitana was Vice President Finance of Bilcare, Inc. a Clinical Supplies and Services company. He established the financial, information technology and purchasing functions for this new US subsidiary of an international parent company. He also helped lead the identification, acquisition and integration of a European subsidiary in Wales. Mr. Napolitana also brings over 15+ years of senior level financial experience with Fortune 500 companies such as Cardinal Health and Fisher Scientific. In these various roles Mr. Napolitana developed expertise in manufacturing and distribution operations along with financial controls and systems implementation and development.
Glenn Schloeffel (Vice President, Sales)
Mr. Schloeffel has more than 15 years of sales and sales management related experience in the medical and pharmaceutical industry. He began his career with Johnson & Johnson in their Diagnostic Hospital Division and progressed to a specialty sales position. He joined Ferndale Laboratories, a specialty pharmaceutical company in 1997 and advanced quickly into a Regional Sales Director. During his tenure with Ferndale Laboratories, Mr. Schloeffel has been part of more than 7 new OTC and branded prescription drug product launches and built multiple sales teams as the company grew from 14 to 80 sales representatives across the country. He has expertise in building new sales forces and sales management teams and related operations, optimizing sales performance, as well as overseeing sales force training. Mr. Schloeffel is a Navy veteran with 21 years of service, retiring from the Naval Reserves in 2001.
H. J